Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on X:
“ROME trial wasn’t built in a day: the decade-long journey to randomized evidence in precision oncology – Annals of Oncology.”
Title: ROME trial wasn’t built in a day: the decade-long journey to randomized evidence in precision oncology
Author: Vivek Subbiah
Read The Full Article
Other articles featuring Vivek Subbiah on OncoDaily.